We hypothesize that ARPC1B promotes ccRCC aggressiveness through activation of the Wnt/β-catenin signaling pathway and induction of epithelial-mesenchymal transition. The gene discussed is ARPC1B; the disease is nonpapillary renal cell carcinoma.